See more : Kurita Water Industries Ltd. (KTWIF) Income Statement Analysis – Financial Results
Complete financial analysis of 1Life Healthcare, Inc. (ONEM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of 1Life Healthcare, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Lake Resources NL (LLKKF) Income Statement Analysis – Financial Results
- Frontage Holdings Corporation (FGHQF) Income Statement Analysis – Financial Results
- Excalibur Global Financial Holdings Limited (8350.HK) Income Statement Analysis – Financial Results
- Anhui Hengyuan Coal-Electricity Group Co., Ltd. (600971.SS) Income Statement Analysis – Financial Results
- HiVi Acoustics Technology Co., Ltd (002888.SZ) Income Statement Analysis – Financial Results
1Life Healthcare, Inc. (ONEM)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.onemedical.com
About 1Life Healthcare, Inc.
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2021, it had 703,000 consumer and enterprise members, and 33,000 At-Risk members; 182 medical offices in 25 markets; and 8,500 enterprise clients in the United States. The company was incorporated in 2002 and is headquartered in San Francisco, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 1.05B | 621.55M | 380.22M | 276.26M | 212.68M | 176.77M |
| Cost of Revenue | 861.16M | 435.18M | 234.96M | 167.62M | 136.18M | 120.71M |
| Gross Profit | 184.39M | 186.37M | 145.26M | 108.64M | 76.50M | 56.06M |
| Gross Profit Ratio | 17.64% | 29.98% | 38.20% | 39.33% | 35.97% | 31.72% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 415.83M | 323.13M | 157.28M | 108.97M | 85.81M | 57.96M |
| Selling & Marketing | 97.07M | 61.99M | 36.97M | 39.52M | 25.79M | 19.17M |
| SG&A | 512.90M | 385.12M | 194.25M | 148.49M | 111.60M | 77.14M |
| Other Expenses | 91.19M | 44.73M | 22.37M | 14.27M | 9.95M | 10.69M |
| Operating Expenses | 604.08M | 429.85M | 216.62M | 162.75M | 121.54M | 87.82M |
| Cost & Expenses | 1.47B | 865.04M | 451.58M | 330.37M | 257.72M | 208.53M |
| Interest Income | 2.02M | 798.00K | 1.81M | 4.50M | 2.25M | 386.00K |
| Interest Expense | 11.68M | 13.76M | 13.43M | 474.00K | 804.00K | 834.00K |
| Depreciation & Amortization | 91.19M | 46.50M | 22.37M | 24.50M | 9.95M | 10.69M |
| EBITDA | -326.50M | -196.19M | -53.03M | -27.49M | -33.64M | -19.15M |
| EBITDA Ratio | -31.23% | -31.56% | -13.95% | -9.95% | -15.82% | -10.83% |
| Operating Income | -417.68M | -242.69M | -71.36M | -54.11M | -45.05M | -31.76M |
| Operating Income Ratio | -39.95% | -39.05% | -18.77% | -19.59% | -21.18% | -17.97% |
| Total Other Income/Expenses | -11.68M | -13.76M | -18.19M | 505.00K | -430.00K | 198.00K |
| Income Before Tax | -429.36M | -256.44M | -89.54M | -53.61M | -45.48M | -31.56M |
| Income Before Tax Ratio | -41.07% | -41.26% | -23.55% | -19.41% | -21.38% | -17.85% |
| Income Tax Expense | -31.51M | -1.80M | -123.00K | 87.00K | 25.00K | 126.00K |
| Net Income | -397.85M | -254.64M | -88.72M | -52.55M | -44.42M | -30.80M |
| Net Income Ratio | -38.05% | -40.97% | -23.33% | -19.02% | -20.88% | -17.42% |
| EPS | -2.02 | -1.66 | -0.75 | -0.43 | -0.48 | -0.29 |
| EPS Diluted | -2.02 | -1.66 | -0.75 | -0.43 | -0.48 | -0.29 |
| Weighted Avg Shares Out | 197.05M | 153.70M | 118.38M | 122.41M | 91.66M | 104.62M |
| Weighted Avg Shares Out (Dil) | 197.05M | 153.70M | 118.38M | 122.41M | 91.66M | 104.62M |
Top 5 Health Care Stocks That Could Blast Off This Month - Azenta (NASDAQ:AZTA), Amgen (NASDAQ:AMGN)
Top 5 Health Care Stocks That May Rally - AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN)
Amazon Could Fuel Doctor Buyouts In 2023 If One Medical Deal Goes Through
Antitrust Reframed: What It Means For These Mergers
These Were The Five Best And Worst Performing Mid-Cap Stocks In Q3 2022
If I Could Buy Only 1 Stock, This Would Be It
How to Play ONEM Stock Ahead of a Potential Amazon Deal
Amazon's One Medical Acquisition Investigated by FTC
FTC investigating Amazon's $3.9B purchase of One Medical
FTC wants more information on Amazon's One Medical purchase
Source: https://incomestatements.info
Category: Stock Reports